oai:pubmedcentral.nih.gov:1102...
BioMed Central
BMC Public Health
2024
11/6/2024
BACKGROUND: Regular HIV and STI testing remain a cornerstone of comprehensive sexual health care.
In this study, we examine the efficacy of Get Connected, a WebApp that combines test locators with personalized educational resources, in motivating young men who have sex with men (YMSM) to undergo regular HIV and STI testing.
METHODS: Participants were randomly placed in one of two conditions.
The first condition included the full version of GC (GC-PLUS), which included content tailored to users’ psychosocial characteristics (e.g., age, race/ethnicity, relationship status, HIV/STI testing history).
The second condition served as our attention-control and only included the testing locator (GC-TLO) for HIV/STI testing services.
Participants were recruited from three cities (Houston, Philadelphia, and Atlanta) characterized by high HIV incidence.
Assessments were collected at 1, 3-, 6-, 9- and 12-month follow-ups.
RESULTS: Both versions of GC were acceptable and efficacious in increasing routine HIV and STI testing over a 12-month period.
40% of the sample reported testing at least twice, with no main effects observed across the two intervention arms (OR = 1.11; 95% CI: 0.69, 1.80), p =.66).
Greater intervention effects were observed among YMSM who engaged more frequently with the intervention, with regional differences observed.
CONCLUSIONS: Our findings underscore the need to cater to the diverse needs of YMSM through multilevel approaches.
Broadly, mHealth HIV/STI testing interventions, such as Get Connected, would benefit from matching technologies to the local context to have the greatest impact.
TRIAL REGISTRATION: This study is registered on ClinicalTrials.gov (NCT03132415).
Bauermeister, J.A.,Horvath, K.J.,Lin, W.Y.,Golinkoff, J.M.,Claude, K.F.,Dowshen, N.,Castillo, M.,Sullivan, P.S.,Paul, M.,Hightow-Weidman, L.,Stephenson, R., 2024, Enhancing routine HIV and STI testing among young men who have sex with men: primary outcomes of the get connected clinical randomized trial (ATN 139), BioMed Central